Bone morphogenetic protein 7 is expressed in prostate cancer metastases and its effects on prostate tumor cells depend on cell phenotype and the tumor microenvironment.
about
Dinosaurs and ancient civilizations: reflections on the treatment of cancerCharacterization of osteoblastic and osteolytic proteins in prostate cancer bone metastases.Curcumin Inhibits Prostate Cancer Bone Metastasis by Up-Regulating Bone Morphogenic Protein-7 in VivoMolecular pathways: niches in metastatic dormancyBone metastasis: mechanisms and therapeutic opportunities.The Yin and Yang of bone morphogenetic proteins in cancer.Metastatic bone disease: role of transcription factors and future targets.Combined inhibition of the BMP pathway and the RANK-RANKL axis in a mixed lytic/blastic prostate cancer lesionThe host microenvironment influences prostate cancer invasion, systemic spread, bone colonization, and osteoblastic metastasis.Berberine inhibits the metastatic ability of prostate cancer cells by suppressing epithelial-to-mesenchymal transition (EMT)-associated genes with predictive and prognostic relevance.Cabozantinib inhibits growth of androgen-sensitive and castration-resistant prostate cancer and affects bone remodelingBone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in boneThe interconnectedness of cancer cell signaling.Suppression of hepatocyte proliferation by hepatocyte nuclear factor 4α in adult mice.Gene expression analysis of bone metastasis and circulating tumor cells from metastatic castrate-resistant prostate cancer patients.Small molecule inhibitor of the bone morphogenetic protein pathway DMH1 reduces ovarian cancer cell growthDeletion of the BMP receptor BMPR1a impairs mammary tumor formation and metastasis.Inhibition of BMP signaling suppresses metastasis in mammary cancerMicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2.The RUNX family in breast cancer: relationships with estrogen signaling.Characterization of an Abiraterone Ultraresponsive Phenotype in Castration-Resistant Prostate Cancer Patient-Derived Xenografts.Prostate cancer cells and bone stromal cells mutually interact with each other through bone morphogenetic protein-mediated signals.PI3K, Erk signaling in BMP7-induced epithelial-mesenchymal transition (EMT) of PC-3 prostate cancer cells in 2- and 3-dimensional cultures.Expression of nodal and nodal receptors in prostate stem cells and prostate cancer cells: autocrine effects on cell proliferation and migration.Current concepts in bone metastasis, contemporary therapeutic strategies and ongoing clinical trials.Contextual effect of repression of bone morphogenetic protein activity in prostate cancer.Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integrationExtracellular matrix proteins and tumor angiogenesis.The Dual Role of Bone Morphogenetic Proteins in Cancer.Differential regulation of hepcidin in cancer and non-cancer tissues and its clinical implications.Multigene profiling of CTCs in mCRPC identifies a clinically relevant prognostic signature.Colorectal adenoma to carcinoma progression is accompanied by changes in gene expression associated with ageing, chromosomal instability, and fatty acid metabolism.
P2860
Q24628746-0CC141E1-7C02-450F-A7E0-0B4D49F2710AQ30596578-7735D10A-F13D-42CB-AD8A-AC4D75D3436AQ33767832-222E6FA3-2DC2-496B-9C29-90F3F66B24C9Q33838536-371DDED1-0B12-4F04-A9FF-9AE0743A6E86Q34025195-EBEA38AA-B66D-44B7-8839-7822B05F2D27Q34127207-39D20F88-AE13-416F-82E4-458286630906Q34217531-09A4E408-6DBE-4E10-BFBD-B05A690C6C7DQ34574593-C86CC2FE-5241-42D3-AFF5-F4FB89EDA3E7Q34699785-DE1734D8-1D48-4BED-B2A4-E580B7DBB8C9Q34784755-7FD92764-57A1-439F-A5FB-3A562703C163Q35036800-88B17F7B-0EF8-4684-B3CE-D5EDF22D37C4Q35627720-6C19FB74-59EF-45E7-AB9A-49B04674BBE9Q35669733-26010B78-DD3F-47AD-8200-51BAF4192691Q35801944-46B624FD-8857-4EBC-8D53-C98733D20474Q35956586-FDD58290-CB58-4659-851D-A0B5B93FCAC9Q36011433-0012704E-36BA-461F-8E4F-519E9D42C143Q36356105-5B4DE223-4C08-43E2-85FC-232DB7179A6AQ36398681-3DB1E386-3C27-4C7B-B255-5A4A274C18C2Q37744995-22CB2EDB-DFC6-444D-8E13-A3A6D80D4031Q38050410-0B5DBF77-8076-4EB9-914B-30D54848220BQ39085996-93F338FA-1354-408D-A275-050DF5D3F029Q39359077-46CD07AF-2465-4395-B7EC-3CC93FBD91FFQ39468018-361AFA62-17FC-4B14-8ADB-CB0205FC8667Q39545341-702ACC06-F482-4EAC-8142-A330223F35C0Q41369617-10453646-AF0B-4F62-9EBD-1C159B4A78D8Q41859712-99725C6C-B059-4584-A536-C67791769933Q41879186-BCE77B13-6FC8-4B6E-91A1-A93C60605F4AQ42699734-93509883-39D6-44E0-B0BF-09E505F5B06FQ47163689-1EE7F6E2-9D17-4CD5-80F6-CD4EB2A89FB8Q49389245-1C4954C2-7522-4521-AB9C-5BDF93DEF58EQ49913687-D7D7F326-3F70-4F95-AC14-DAF3CED89D7FQ52620979-ECCB44C9-41F7-4383-B26A-6F22222444C2
P2860
Bone morphogenetic protein 7 is expressed in prostate cancer metastases and its effects on prostate tumor cells depend on cell phenotype and the tumor microenvironment.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Bone morphogenetic protein 7 i ...... nd the tumor microenvironment.
@ast
Bone morphogenetic protein 7 i ...... nd the tumor microenvironment.
@en
type
label
Bone morphogenetic protein 7 i ...... nd the tumor microenvironment.
@ast
Bone morphogenetic protein 7 i ...... nd the tumor microenvironment.
@en
prefLabel
Bone morphogenetic protein 7 i ...... nd the tumor microenvironment.
@ast
Bone morphogenetic protein 7 i ...... nd the tumor microenvironment.
@en
P2093
P2860
P356
P1433
P1476
Bone morphogenetic protein 7 i ...... nd the tumor microenvironment.
@en
P2093
Colm Morrissey
Lisha G Brown
Robert L Vessella
Tiffany E M Pitts
P2860
P304
P356
10.1593/NEO.91836
P577
2010-02-01T00:00:00Z